These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 17598508)

  • 1. Prevalence of human papillomavirus among Croatian women attending regular gynecological visit.
    Grahovac M; Racić I; Hadzisejdić I; Dorić A; Grahovac B
    Coll Antropol; 2007 Apr; 31 Suppl 2():73-7. PubMed ID: 17598508
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevaccination distribution of human papillomavirus types in women attending at cervical cancer screening in Belgium.
    Arbyn M; Benoy I; Simoens C; Bogers J; Beutels P; Depuydt C
    Cancer Epidemiol Biomarkers Prev; 2009 Jan; 18(1):321-30. PubMed ID: 19124515
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Retrospective study of the prevalence of high-risk human papillomaviruses among Croatian women.
    Milutin-Gasperov N; Sabol I; Halec G; Matovina M; Grce M
    Coll Antropol; 2007 Apr; 31 Suppl 2():89-96. PubMed ID: 17598510
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epidemiologic correlates of cervical human papillomavirus prevalence in women with abnormal Pap smear tests: a Taiwan Cooperative Oncology Group (TCOG) study.
    Sun CA; Hsiung CA; Lai CH; Chen CA; Chou CY; Ho CM; Twu NF; Feng WL; Chuang MH; Hsieh CY; Chu TY
    J Med Virol; 2005 Oct; 77(2):273-81. PubMed ID: 16121376
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genital human papillomavirus infection in women from the Zagreb region.
    Marijan T; Vranes J; Mlinarić-Dzepina A; Leskovar V; Knezević J; Kvaternik M
    Coll Antropol; 2007 Apr; 31 Suppl 2():83-7. PubMed ID: 17600936
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence and risk factors of human papillomavirus infection in asymptomatic women in a Venezuelan urban area.
    Núñez-Troconis J; Delgado M; González J; Mindiola R; Velásquez J; Conde B; Whitby D; Munroe DJ
    Invest Clin; 2009 Jun; 50(2):203-12. PubMed ID: 19662815
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Detection and typing of human papilloma virus by polymerase chain reaction and hybridization assay in cervical samples with cytological abnormalities].
    Ergünay K; Misirlioğlu M; Firat P; Tuncer ZS; Tuncer S; Yildiz I; Ustaçelebi S
    Mikrobiyol Bul; 2008 Apr; 42(2):273-82. PubMed ID: 18697425
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HPV prevalence among Mexican women with neoplastic and normal cervixes.
    Torroella-Kouri M; Morsberger S; Carrillo A; Mohar A; Meneses A; Ibarra M; Daniel RW; Ghaffari AM; Solorza G; Shah KV
    Gynecol Oncol; 1998 Jul; 70(1):115-20. PubMed ID: 9698486
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An association of cervical inflammation with high-grade cervical neoplasia in women infected with oncogenic human papillomavirus (HPV).
    Castle PE; Hillier SL; Rabe LK; Hildesheim A; Herrero R; Bratti MC; Sherman ME; Burk RD; Rodriguez AC; Alfaro M; Hutchinson ML; Morales J; Schiffman M
    Cancer Epidemiol Biomarkers Prev; 2001 Oct; 10(10):1021-7. PubMed ID: 11588127
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Resolution of equivocal results with the Hybrid Capture II high-risk HPV DNA test: a cytologic/histologic review of 191 cases.
    Knoepp SM; Kuebler DL; Wilbur DC
    Diagn Mol Pathol; 2007 Sep; 16(3):125-9. PubMed ID: 17721319
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence and type distribution of high-risk human papillomavirus infection in women undergoing voluntary cervical cancer screening in Italy.
    Agarossi A; Ferrazzi E; Parazzini F; Perno CF; Ghisoni L
    J Med Virol; 2009 Mar; 81(3):529-35. PubMed ID: 19152401
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low-risk human papillomavirus type 6 DNA load and integration in cervical samples from women with squamous intraepithelial lesions.
    Coutlée F; Trottier H; Gagnon S; Koushik A; Richardson H; Roger M; Ferenczy AS; Franco EL
    J Clin Virol; 2009 Jun; 45(2):96-9. PubMed ID: 19398216
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of human papillomavirus types 6, 11, 16, 18, 31, and 33 in a cohort of Greek women.
    Panotopoulou E; Tserkezoglou A; Kouvousi M; Tsiaousi I; Chatzieleftheriou G; Daskalopoulou D; Magiakos G
    J Med Virol; 2007 Dec; 79(12):1898-905. PubMed ID: 17935171
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HPV genotypes in women with squamous intraepithelial lesions and normal cervixes participating in a community-based microbicide study in Pretoria, South Africa.
    Said HM; Ahmed K; Burnett R; Allan BR; Williamson AL; Hoosen AA
    J Clin Virol; 2009 Apr; 44(4):318-21. PubMed ID: 19269889
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of high-risk human papillomavirus type 16/18 infection among women with normal cytology: risk factor analysis and implications for screening and prophylaxis.
    Gupta S; Sodhani P; Sharma A; Sharma JK; Halder K; Charchra KL; Sardana S; Singh V; Sehgal A; Das BC
    Cytopathology; 2009 Aug; 20(4):249-55. PubMed ID: 19018810
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A meta-analysis of human papillomavirus type-distribution in women from South Asia: implications for vaccination.
    Bhatla N; Lal N; Bao YP; Ng T; Qiao YL
    Vaccine; 2008 Jun; 26(23):2811-7. PubMed ID: 18450340
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Easy and fast detection and genotyping of high-risk human papillomavirus by dedicated DNA microarrays.
    Albrecht V; Chevallier A; Magnone V; Barbry P; Vandenbos F; Bongain A; Lefebvre JC; Giordanengo V
    J Virol Methods; 2006 Nov; 137(2):236-44. PubMed ID: 16879879
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human papillomavirus type-distribution in the cervix of Chinese women: a meta-analysis.
    Bao YP; Li N; Smith JS; Qiao YL
    Int J STD AIDS; 2008 Feb; 19(2):106-11. PubMed ID: 18334063
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adjunctive high-risk human papillomavirus DNA testing is a useful option for disease risk assessment in patients with negative Papanicolaou tests without an endocervical/transformation zone sample.
    Zhao C; Austin RM
    Cancer; 2008 Aug; 114(4):242-8. PubMed ID: 18484643
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distribution and prevalence of human papillomavirus genotypes in routine pap smear of 2,470 korean women determined by DNA chip.
    Hwang HS; Park M; Lee SY; Kwon KH; Pang MG
    Cancer Epidemiol Biomarkers Prev; 2004 Dec; 13(12):2153-6. PubMed ID: 15598774
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.